55 North Announces First Close for Record €300M Quantum Technology Fund
55 North, the world’s largest dedicated quantum technology venture capital fund, today announced the first close of its €300m inaugural Fund I at €134 million, establishing its position as the sector’s largest pure-play quantum VC. The fund was co-founded by three founding GPs, Owen Lozman, Dr. Helmut Katzgraber and Dr. Kai Hudek, who are expert quantum and deep-tech specialists; EIFO (the Export and Investment Fund of Denmark), and Novo Holdings, as anchor investors; and European VC firm Vsquared Ventures and US-based Cambium Capital. Headquartered in Denmark, 55 North will be investing stage-agnostically across the globe, and has already executed two investments, backing European quantum leader IQM in the company’s latest €275m Series B, and co-leading the investment in Kiutra’s €13m Series A-2.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002543160/en/
Core team 55 North
Quantum technologies have become a strategic priority at national, European, and global levels, with the EU, UK, Germany, France, and Denmark embedding them into core security and innovation frameworks. The G7 recently pledged coordinated action amid $40 billion in global public funding - underscoring that leadership is now critical for economic sovereignty, climate resilience, and national security, across the globe. The Danish government, which launched its National Strategy for Quantum Technology in 2023, has firmly committed to advancing the field as part of its long-term innovation agenda, which included the mandate for EIFO to spearhead the creation of a world-leading quantum investment fund. Against this backdrop, the anchoring of 55 North by EIFO and Novo Holdings marks a significant step in strengthening the global quantum ecosystem and its headquartering in Denmark provides the fund with access to a central hub of expertise and innovation, the ideal base for the fund to invest in quantum technologies across the globe.
The fund is led by Managing Partner Dr. Owen Lozman FRSC (ex M Ventures) alongside General Partners Dr. Helmut Katzgraber (ex Amazon, ex Microsoft), and Dr. Kai Hudek (ex IonQ). They are supported by Vsquared Ventures and Cambium Capital. The team, with roots from across Europe, the UK and the US, bring deep entrepreneurial and technological expertise, having built, run and backed successful deep tech ventures across the globe.
“Quantum is no longer a science experiment, it’s a strategic imperative,” said Dr. Owen Lozman, Managing Partner of 55 North. “As classical computing nears its physical and computational limits in applications like drug discovery and AI, quantum is well positioned to accelerate these workloads. Europe must push its quantum agenda to remain a producer, not just a buyer of quantum technologies. With our first close and early investments, we’re laying the foundation for the world’s quantum future.”
2025, the UN’s international year of quantum science and technology, marks 100 years of quantum mechanics and has emerged as a pivotal year with quantum investment surging to over €1 billion in Q1 alone, despite a 50% drop in overall tech investments1. This marks more than double the invested capital than the previous year, as the global quantum market reached $1.45 billion in 2024, with projections to hit $5.4 billion by 20302. This represents the decisive shift from quantum as a long-term research endeavour to commercial readiness, marking an unprecedented opportunity for advancements in the field. This movement is recognized across the globe, and has established itself as a long-term strategic focus, especially in Denmark, with its deep quantum heritage, who is building on its legacy to establish a global innovation hub for quantum technologies.
Peder Lundquist, CEO, EIFO: “We are thrilled to see 55 North launch. To fulfil the strategic objective of the Danish Government, we have teamed up with strategic partners to incubate a world-leading platform ready to invest in the important field of quantum technology. Quantum will shape industries, economies, and security frameworks worldwide. That is why Europe must act decisively to secure a leading position. With an outstanding team and solid backing from us, Novo Holdings, and further investors to come, 55 North is set to play a defining role.”
Søren Møller, Managing Partner, Novo Holdings:“We are very pleased to act as cornerstone investors in 55 North alongside EIFO, which shares our conviction that quantum innovation holds the potential to address some of the most critical challenges in human and planetary health. Innovation requires capital, and it is therefore essential to make the necessary resources available to the companies that create the solutions of tomorrow. This marks an important step in Novo Holdings’ quantum investment strategy, where we aim to back the most promising companies driving progress in the field. We see quantum technologies as a transformative enabler of life science solutions that can ultimately improve the health of people and the planet worldwide.”
Morten Bødskov, Danish Minister for Industry, Business and Financial Affairs: “We need to seize the potential of quantum technology. It can help us solve some of the major challenges we are facing. Just look at the opportunities within, for example, cybersecurity and supply chain optimization. But courage and investment are needed. In Denmark, we proudly carry on Niels Bohr’s legacy as we inaugurate the world’s largest quantum fund today. With it, we can invest in the major quantum breakthroughs of the future and more quickly get ideas out of the labs and into our society.”
55 North’s highly specialized approach focuses exclusively on quantum technologies, investing across three complementary areas that together constitute the complete quantum ecosystem: computing, sensing, and communication. Backing companies that reshape industry, accelerate discovery, and drive global progress, its investments will target enabling technologies, full stack solutions, and software and algorithms designed to solve real world problems. This diversified approach balances short-term commercial traction with long-term ambition, while creating synergies between portfolio companies that accelerate the entire field.
55 North’s initial two investments exemplify this strategic thesis and commercial approach. The €275 million Series B financing of IQM is the largest round raised by a European quantum technology company. IQM has installed the largest number of on-premises quantum computers in Europe and offers cloud access to quantum computing resources. The fund co-led the €13 million Series A-2 in Germany-based Kiutra, who are developing advanced cryogenic cooling systems, essential for efficient operation at the ultra-low cryogenic temperatures required for quantum computing and sensing.
The fund's focus on European quantum leadership aligns with EU initiatives to maintain technological independence in critical computing infrastructure as quantum technologies transition from research labs to commercial deployment.
| _____________________________ |
2https://quantumconsortium.org/publications/stateofthequantumindustry2025/#about, https://www.researchandmarkets.com/reports/ |
About 55 North
55 North is a Copenhagen-based venture capital fund exclusively focused on the quantum technology stack and invests with a long-term investment horizon. It invests in startups at all stages, developing quantum computing, quantum communications, sensing and other enabling technologies. The team combines deep technical expertise with a proven investment track record, partnering with world-class investors, scientists and entrepreneurs to advance breakthrough quantum solutions. Supporting companies worldwide and targeting real-world applications that deliver significant economic and societal value - 55 North is committed to establishing Europe as a global hub for quantum innovation. 55n.vc
View source version on businesswire.com: https://www.businesswire.com/news/home/20251002543160/en/
Contacts
Media contact, 55 North:
Gina Krymalowski
Email: gina@vsquared.vc
Media contact, Novo Holdings:
Vici Rabbets
vici@optimumcomms.com
Media contact, EIFO:
Ina Bjerregaard-Castenborg
ibc@eifo.dk
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Marathon Asset Management Provides Junior Capital Financing to EXALTA Group15.12.2025 15:00:00 CET | Press Release
Marathon Asset Management (“Marathon”), a leading global credit manager with more than $24 billion of assets under management, is pleased to announce the closing of a junior capital financing to EXALTA Group (“EXALTA” or the “Company”), a portfolio company of Montagu. Marathon led the financing that supported the formation of EXALTA through the strategic merger of three Montagu-owned companies including Intech, Resolve Surgical Technologies, and Tyber Medical. The transaction marks one of many successful transactions for Marathon’s European Credit business in the healthcare sector, where the firm has a knowledge-based advantage with a dedicated Healthcare Finance business and specialized medical advisory board providing sector insight to middle market companies. EXALTA is a global leader in orthopaedic contract design and manufacturing for spine, trauma, extremities, sports medicine and enabling technology providing comprehensive solutions to OEMs within the medical technology industry
Aurobay Technologies Expands Digital Transformation Partnership With HCLTech to Boost Manufacturing Excellence and Innovation15.12.2025 14:29:00 CET | Press Release
HCLTech, a leading global technology company, and Aurobay Technologies, a division of Horse Powertrain and a global leader in hybrid and low-emission powertrain solutions, have expanded their digital transformation partnership to support Aurobay’s global growth strategy. The expanded partnership establishes HCLTech as Aurobay Technologies’ trusted partner for managing and optimizing SAP, Siemens Teamcenter PLM software and integration services in Sweden and China. This will unlock cost efficiency, operational resilience and digital innovation across Aurobay’s manufacturing and engineering functions by leveraging HCLTech’s flagship service transformation platform, AI Force. The engagement spans core business functions including SAP operations, engineering systems, integration services and mainframe environments, reinforcing Aurobay’s focus on scale, efficiency and seamless operations across global locations. “Horse Powertrain’s division Aurobay Technologies’ digital transformation conti
Applications Now Open for the 5th Cycle of the Mohammed bin Rashid Al Maktoum Global Water Award15.12.2025 14:28:00 CET | Press Release
HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE), announced the opening of applications for the 5th cycle of the Mohammed bin Rashid Al Maktoum Global Water Award, offering USD 1 million in prizes. The award seeks to inspire innovative, clean energy–powered solutions for water production, distribution, storage, desalination and purification, supporting global sustainability efforts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215897854/en/ HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE) - (Photo: AETOSWire) “Since its establishment, Suqia UAE, launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has provided clean water to nearly 15 million people in 37 countries worldwide through sustainable development and humanitarian projects.
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom